PENG vs. QLB vs. Lumbar ESPB in Total Hip Surgery
Comparison of Pericapsular Nerve Group Block, Quadratus Lumborum Block and Lumbar Erector Spinae Plane Block for Acute Pain Management in Total Hip Surgery: A Randomized Clinical Trial
1 other identifier
interventional
60
1 country
1
Brief Summary
The aim of this study is to compare between Pericapsular Nerve Group Block, Erector Spinae Plane Block and Quadratus Lumborum Block for managing acute postoperative pain in patients undergoing total hip surgeries under spinal anesthesia.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Dec 2022
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 26, 2022
CompletedFirst Posted
Study publicly available on registry
October 31, 2022
CompletedStudy Start
First participant enrolled
December 15, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 10, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
October 10, 2023
CompletedSeptember 6, 2023
September 1, 2023
10 months
October 26, 2022
September 3, 2023
Conditions
Outcome Measures
Primary Outcomes (1)
Total amount of rescue analgesia
Total amount of rescue analgesia in the form of morphine will be recorded
24 hours postoperatively
Secondary Outcomes (3)
First analgesic request
24 hours Postoperatively
Pain level
48 hours Postoperatively
Adverse events
48 hours Postoperatively
Study Arms (3)
PENG block Technique
EXPERIMENTALPatients will receive ultrasound-guided Pericapsular Nerve Group Block using 30 ml bupivacaine 0.25%.
Lumbar ESPB Technique
EXPERIMENTALPatients will receive lumbar erector spinae plane block using 30 ml bupivacaine 0.25%
Transmuscular QLB-t block Technique
EXPERIMENTALPatients will receive transmuscular quadratus lumborum block using 30 ml bupivacaine 0.25%
Interventions
A linear probe will be used. Puncture will be performed in a lateromedial direction until the needle tip reached the plane between the iliopsoas tendon and periosteum and between the anterior inferior iliac spine and iliopubic eminence. After a negative aspiration test, 30 ml of bupivacaine 0.25% will be injected in the plane beneath the iliopsoas muscle
Using the out-plane technique, a 22G/80-mm block needle will be advanced until it reached the transverse process. 0.5-1 ml of the prepared local anesthetic solution, 30 ml bupivacaine 0.25% will be administered leading to hydrodissection to confirm the correct location. The needle will be repositioned by pulling back a few millimeters if resistance occurs when administering local anesthetic . All local anesthetic will be administered to this location between the transverse process and the erector spinae muscle
A convex transducer will be placed in the transverse plane on the flank of the patient cranial to the iliac crest. The 4th lumbar vertebral transverse process, erector spinae muscles, psoas muscle, transverse abdominis muscle, internal and externa oblique muscles, and the quadratus lumborum muscle will be identified. A 15 cm 22G insulated needle will be inserted on the posterior corner of the transducer. 30 ml bupivacaine 0.25% will be administered between the quadratus lumborum and psoas muscles into the fascial plane.
Eligibility Criteria
You may qualify if:
- Age 18-65 years
- Both genders
- Body mass index \< 40 kg/m\^2
- American Society of Anesthesiologists (ASA) physical status I-III
- Posted for total hip surgeries under spinal anesthesia
You may not qualify if:
- The presence of contraindications or allergy to local anesthetic agents
- Chronic use of opioids or corticosteroids
- Infection at the puncture site
- Coagulopathy
- Psychiatric disorders (dementia or cognitive impairment.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Mohammad Fouad Algyar
Tanta, ElGharbiaa, 31511, Egypt
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Lecturer of Anesthesiology, Surgical Intensive Care and Pain Medicine
Study Record Dates
First Submitted
October 26, 2022
First Posted
October 31, 2022
Study Start
December 15, 2022
Primary Completion
October 10, 2023
Study Completion
October 10, 2023
Last Updated
September 6, 2023
Record last verified: 2023-09
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL
- Time Frame
- One year after the end of the study
The data will be available under a reasonable request from the corresponding author.